Naturopathica FatBlaster FatMagnet (Cat Media Pty Ltd)

The sponsor did not hold evidence to support the claim about maintaining general health and wellbeing. The sponsor did not hold sufficient evidence to support claims relevant to reducing dietary fat absorption and aiding elimination of dietary fat, which were advertised on the label and website for the medicine. The clinical trials provided had limitations including not providing enough detail about the study population to be sure it is relevant to the target population of the medicine; the dosage of the active ingredients was different to the dosage in the medicine; information about the monitoring of food intake was unclear; unexplained dropout of participants; possible conflict of interests; and the effect of the medicine ingredients on dietary fat absorption or dietary fat elimination was not assessed.The remaining evidence included review articles, animal studies, in vitro laboratory studies and an evidence-based textbook. These types of evidence are insufficient in the absence of robust scientific studies, such as clinical trials or systematic reviews, to support these claims. This is because they generally do not include sufficient detail regarding population demographics, sample size, ingredient preparation, dose and statistical analysis to allow for comparison with the medicine.The name of the medicine was considered to be misleading, as it suggests that the medicine can help with fat loss or weight reduction, yet these claims were not covered by a certification by the sponsor that they held evidence to substantiate them.